News

The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ...
In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years.
Decongestant sprays shouldn't be used for more than a week - but those who don't realise can become trapped in a cycle of ...
Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved VALTOCO® (diazepam nasal spray) for short-term treatment of seizure clusters (also known as "acute repetitive ...
Decongestant sprays shouldn't be used for more than a week - but those who don't realise can become trapped in a cycle of ...
ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...
If I didn't take the spray I couldn't breathe ... Most patients are capable of weaning themselves off the drug and suffer no long-term nasal damage, she said. Medics have also provided ...
SELF-ADMINISTERED etripamil, an intranasal calcium channel blocker, significantly reduces emergency department (ED) visits ...